SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid organ transplant (SOT) recipients. Mortality rates of COVID-19 in this patient population remain high, despite new available therapeutic options and Severe Acute Respiratory Syndrome Coronavirus 2 (SAR...
Main Authors: | Maddalena Peghin, Elena Graziano, Paolo Antonio Grossi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/9/1430 |
Similar Items
-
Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review
by: Bo Yu, et al.
Published: (2023-11-01) -
Leukocyte Count in Solid Organ Transplant Recipients After SARS-CoV-2 mRNA Vaccination and Infection
by: Marita Kern, et al.
Published: (2025-01-01) -
Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients
by: Pierluigi Toniutto, et al.
Published: (2023-06-01) -
SARS-CoV-2 in Kidney Transplant Recipients: A Systematic Review
by: Naveen Kumar, et al.
Published: (2022-01-01) -
Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipients
by: Chien-Chia Chen, et al.
Published: (2022-09-01)